Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00601237 · ClinicalTrials.gov registry record · NA
Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
A NA study of HIV Infections, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT00601237: Completed NA study of HIV Infections, sponsored by University of Colorado, Denver.
NCT00601237 is a NA study of HIV Infections that has completed, run by University of Colorado, Denver. The registered enrollment target is 103 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00601237, a NA study of HIV Infections, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop and test the effectiveness of a cell phone-based text messaging program to encourage abstinence, monogamy, or condom use among black urban males in Philadelphia, Pennsylvania.
Conditions Studied
Interventions
- BEHAVIORAL HIV-related text messaging
- BEHAVIORAL Nutrition-related text messaging
Study Locations (1)
Pennsylvania
- Motivational Educational Entertainment (MEE) Productions - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT00601237 record still lists
NCT00601237 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (77% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which HIV-related text messaging is the first listed.
NCT00601237 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00601237 about?
NCT00601237 is a clinical study titled "Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention". This study will develop and test the effectiveness of a cell phone-based text messaging program to encourage abstinence, monogamy, or condom use among black urban males in Philadelphia, Pennsylvania.
What is the current status of trial NCT00601237?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2008-10. Estimated completion is 2013-05.
What conditions does trial NCT00601237 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00601237?
The interventions under investigation include: HIV-related text messaging (BEHAVIORAL), Nutrition-related text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT00601237?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00601237 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00601237's enrollment target sits among peer trials
103 261st of 542 higher than 281 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia